Human influenza virus A/HongKong/156/97 (H5N1) infection

By Claas E.C.J.   de Jong J.C.   van Beek R.   Rimmelzwaan G.F.   Osterhaus A.D.M.E.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 977-978

Elsevier

Access to resources Recommend Favorite

Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate

By Chen H.   Subbarao K.   Swayne D.   Chen Q.   Lu X.   Katz J.   Cox N.   Matsuoka Y.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1983-1988

Elsevier

Access to resources Recommend Favorite

ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus

By Rimmelzwaan G.F.   Claas E.C.J.   Van Amerongen G.   de Jong J.C.   Osterhaus A.D.M.E.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1355-1358

Elsevier

Access to resources Recommend Favorite

Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes

By Van Reeth K.   Gregory V.   Hay A.   Pensaert M.  

Vaccine, Vol. 21, Iss. 13, 2003-03 ,pp. : 1375-1381

Elsevier

Access to resources Recommend Favorite

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

By Treanor J.J.   Kotloff K.   Betts R.F.   Belshe R.   Newman F.   Iacuzio D.   Wittes J.   Bryant M.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 899-906

Elsevier

Access to resources Recommend Favorite